Ocular Pain Management in the Opioid Epidemic with Blair Lonsberry, OD
Lonsberry recommends alternative approaches to manage postoperative pain, balancing the need for relief against the risk of addiction and death.
Related Articles
Timing Matters in Prediabetes Remission, with Arvid Sandforth, MD
Sandforth discussed his research that found that early prediabetes remission conferred greater protective effects against T2D than later remission.
Frequent HCV Testing Cost-Effective Among PWID, Analysis Suggests
Study findings highlight the cost-effectiveness of more frequent HCV testing among people who inject drugs compared with no testing and less frequent testing.
Tackling Real-World Barriers in Scalp Psoriasis Treatment Delivery
In this video, the first in a 6-part series, panelists discuss recent advancements in PsO management.
Study Highlights Experiences with Familial Chylomicronemia Syndrome After Olezarsen Use
These data resulted from a sub-study of the open-label extension (OLE) of the randomized, placebo-controlled phase 3 ‘Balance’ analysis.
Frequent HCV Testing Cost-Effective Among PWID, Analysis Suggests
Study findings highlight the cost-effectiveness of more frequent HCV testing among people who inject drugs compared with no testing and less frequent testing.
Q2 2025 Recap: Cardiology News and Updates
Our recap of Q2 2025 in cardiology spotlights 3 FDA headlines, trial news, and new episodes of Don’t Miss a Beat.
Study Highlights Experiences with Familial Chylomicronemia Syndrome After Olezarsen Use
These data resulted from a sub-study of the open-label extension (OLE) of the randomized, placebo-controlled phase 3 ‘Balance’ analysis.
New Insight: The eSight Go with Roland Mattern, eSight Director of Marketing
Veeral Sheth, MD, is joined by the director of marketing of eSight to discuss the 5th generation eSight Go, a device to enhance central vision…
One in 4 Older Adults Taking Preventative Aspirin Never Got a Doctor’s OK
New data from a UMichigan survey found that 8% of preventative aspirin users had not even discussed their use with any health care provider.
Finerenone Maintains Benefits in HFmrEF, HFpEF Regardless of Frailty Status
The prespecified analysis of FINEARTS-HF found finerenone’s impact on HF events, cardiovascular death, and symptoms was not impacted by frailty.